Clinical Trials Sponsored by PuriCore, Inc.

Total 35721 results

Mylan Inc.
Mylan GmbH

Completed

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) (INSTRIDE 2)

Type 2 Diabetes

United States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
Mylan Inc.
Mylan GmbH

Completed

Mylan Insulin Glargine Study

Diabetes Mellitus, Type 1

United States
Mylan Inc.
Mylan GmbH

Completed

Mylan Insulin Aspart Study

Diabetes Mellitus, Type 1

United States
Mylan Inc.
Theravance Biopharma

Completed

Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease, COPD

New Zealand
Mylan Inc.
Theravance Biopharma

Completed

A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | COPD

United States
Mylan Inc.
Theravance Biopharma

Completed

A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
Mylan Inc.
Theravance Biopharma

Completed

Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment

Renal Impairment

United States
Northside Hospital, Inc.
Millennium Pharmaceuticals, Inc.

Completed

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Multiple Myeloma | Acute Leukemia | Myelodysplastic Syndrome | Lymphomas | Chronic Leukemia

United States
Trust Bio-sonics, Inc.
StatPlus,Inc.

Completed

A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography

Cardiac Disease

Taiwan
Relypsa, Inc.
Medpace, Inc.

Completed

Evaluation of Patiromer in Heart Failure Patients (PEARL-HF)

Heart Failure | Hyperkalemia

United States, Czechia, Georgia, Germany, Poland, Russian Federation, Ukraine
Merit Medical Systems, Inc.
CryoLife, Inc.

Withdrawn

Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis

End Stage Renal Failure on Dialysis

United States
KGK Science Inc.
InterHealth Nutraceuticals, Inc.

Completed

A Study to Investigate the Effect of 7-Keto on Resting Metabolic Rate in Overweight Adults (15KMHI)

Resting Metabolic Rate | Overweight Subjects

United States
Freedom Laser, Inc.
NST Consultants, Inc.

Completed

Evaluation of LLLT/Music for Smoking Cessation

Nicotine Dependence, Cigarettes

United States
Palatin Technologies, Inc
AMAG Pharmaceuticals, Inc.

Completed

2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
Evofem Inc.
Clinical Research Management, Inc.

Completed

Phase 2B/3 Double-blinded Placebo-controlled

Chlamydia Trachomatis Infection

United States
Ulthera, Inc

Terminated

Simulines Non-Inferiority Pivotal Study

Skin Laxity

United States
Astellas Pharma Inc
Immunomic Therapeutics, Inc.

Completed

A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy

Cedar Pollinosis

Japan
Merz North America, Inc.
Ulthera, Inc

Completed

Study of the Cabochon System for Improvement in the Appearance of Cellulite

Gynoid Lipodystrophy

United States
MedicaSafe, Inc.
Friends Research Institute, Inc.

Unknown

Improving Office Based Treatment of Opioid Use Disorder With Technology

Opioid-use Disorder

United States
Duke University
Genentech, Inc.; Eisai Inc.

Terminated

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme | Gliosarcoma

United States
Intermountain Health Care, Inc.
Savvysherpa, Inc.

Completed

Pilot and Feasibility Study of a MAWDS (Medications, Activity, Weight, Diet and Symptoms) Heart Failure Mobile Platform (iMAWDS)

Heart Failure

United States
Ulthera, Inc

Completed

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

Wrinkles | Skin Laxity

United States
Ulthera, Inc

Completed

Ulthera® System for Treating Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

United States
Ulthera, Inc

Completed

Reducing Wrinkles Around the Eyes Using the Ulthera® System

Periorbital Wrinkles

United States
Ulthera, Inc

Completed

Treatment of the Face and Neck With Lower Ulthera System Energy Settings

Skin Laxity

United States
Ulthera, Inc

Completed

Evaluation of the Ulthera® System for Treatment of the Brachia

Brachial Ptosis

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Lifting and Tightening Neck Skin in Patients

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Ulthera System for the Treatment of Rosacea

Erythematotelangiectatic Rosacea

Canada
Ulthera, Inc

Completed

Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis

Hyperhidrosis

United States
Ulthera, Inc

Terminated

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

Skin Laxity

United States
Niiki Pharma Inc.

Completed

Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors

Solid Tumors

United States
Xoft, Inc.
Eminence Clinical Research, Inc.

Unknown

Electronic Brachytherapy (eBx)-Mohs Matched Pair - Cohort Study A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melanoma Skin Cancer Patients Treated With Mohs Surgery

Nonmelanoma Skin Cancer

United States
Nutrisystem, Inc.
Biofortis Clinical Research, Inc.

Completed

Study to Evaluate Effects of a Weight Loss Program in Different Formats on Healthy Adults

Weight Loss | Overweight and Obesity
Glo Science, Inc.
EEC Institute, Inc.

Completed

Evaluating the Efficacy of a Gum Health Formulation on Teeth Whitening in Patients With Gingivitis and Periodontitis

Periodontal Diseases | Tooth Discoloration

United States
IQuum, Inc.
Roche Molecular Systems, Inc

Completed

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

United States
KC BioMediX, Inc
Innara Health, Inc.

Unknown

Trial of Patterned Oral Somatosensory Entrainment for Shortening Time to Oral Feeding

Infant, Extremely Premature | Length of Stay | Feeding

United States
KGK Science Inc.
Boston Biopharm, Inc.

Completed

A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product (15PCHB)

Healthy

Canada
CSA Medical, Inc.
Reset Medical, Inc.

Withdrawn

CryoSpray Ablation(tm)Thoracic Patient Registry

Asthma | Emphysema | Lung Cancer | Mesothelioma | COPD | Sarcoidosis | Chronic Bronchitis
Toray Industries, Inc
Astellas Pharma Inc

Completed

TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Chronic Renal Failure | Glomerular Disease | Nephrosclerosis

China, Hong Kong, Taiwan, Malaysia, Japan, Korea, Republic of, Thailand
Astellas Pharma Inc
Toray Industries, Inc

Completed

Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males

Healthy Adult Male | Pharmacokinetics of TRK-100-STP

Japan
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

To Determine the Bioequivalence Study Under Fasting

Canada
Par Pharmaceutical, Inc.
PharmaKinetics Laboratories Inc.

Completed

Comparative Bioavailability Study of Lisinopril Tablets, 10 mg

Healthy

United States
Sirion Therapeutics, Inc.
ReVision Therapeutics, Inc.

Completed

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Geographic Atrophy | Dry Age Related Macular Degeneration
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions

Healthy

Canada
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

Healthy

Canada
Par Pharmaceutical, Inc.
Algorithme Pharma Inc

Completed

Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting Conditions

Healthy
Verrica Pharmaceuticals Inc.
BioClinica, Inc.; Paidion Research, Inc.; Instat Consulting, Inc.; ALMAC Clinical...

Completed

Cantharidin and Occlusion in Verruca Epithelium (COVE-1)

Skin Diseases | Virus Diseases | DNA Virus Infections | Skin Diseases, Infectious | Warts | Papillomavirus Infections | Skin Diseases, Viral | Tumor Virus Infections | Common Wart | Verruca Vulgaris | Warts Hand | Verruca

United States
Astellas Pharma Global Development, Inc.
Seagen Inc.

Recruiting

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Carcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBC

United States, Canada, France, Spain, United Kingdom, Germany
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
CytoPharm, Inc.

Completed

Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C

Hepatitis C, Chronic

Taiwan

Clinical Trials Sponsored by PuriCore, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations